𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gemcitabine-based combination treatment of pancreatic cancer

✍ Scribed by Volker Heinemann

Book ID
114481173
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
107 KB
Volume
29
Category
Article
ISSN
0093-7754

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combined gemcitabine and radioimmunother
Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancer
✍ Thomas M. Cardillo; Rosalyn Blumenthal; Zhiliang Ying; David V. Gold πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 116 KB πŸ‘ 1 views

## Abstract MAb‐PAM4 is an anti‐MUC1 antibody that has been shown to be reactive with 85% of pancreatic adenocarcinomas with no reactivity with normal pancreas or other tissues. Initial clinical studies have shown excellent targeting with high tumor/nontumor ratios. Gemcitabine, an analog of deoxyc

The pemetrexed/gemcitabine combination i
The pemetrexed/gemcitabine combination in pancreatic cancer
✍ Hedy Lee Kindler πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 89 KB

Gemcitabine has modest antitumor activity in advanced pancreatic cancer. New agents are clearly needed. Pemetrexed (ALIMTA) is a novel antifolate that inhibits thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase. Pemetrexed has shown in vitro activity agai

Gemcitabine and platinum combinations in
Gemcitabine and platinum combinations in pancreatic cancer
✍ Philip Agop Philip πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 62 KB

Progress in the treatment of pancreatic cancer in the past several decades has been very modest. Several new agents with activity against this disease have been identified. Of these, gemcitabine appears to be the most promising when used in combination with other drugs. Gemcitabine and cisplatin com